## BACKGROUND. Resistance to chemotherapy agents is a major problem in the treatment of patients with nonsmall cell lung carcinoma (NSCLC). Recent studies have indicated that glutathione S-transferase-n (GST-n) may play an important role in the resistance of cancer cells to alkylating agents, inclu
Immunohistochemical expression of glutathione S-transferase πι can predict chemotherapy response in patients with nonsmall cell lung carcinoma
- Book ID
- 123010364
- Publisher
- Elsevier Science
- Year
- 1997
- Tongue
- English
- Weight
- 137 KB
- Volume
- 16
- Category
- Article
- ISSN
- 0169-5002
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## BACKGROUND Glutathione S‐transferase (GST) π (GSTP1) is a detoxification enzyme with substrate specificity for both exogenous carcinogens and chemotherapy agents. Genetic polymorphisms of __GSTP1__ exon 5 (Ile105Val) and exon 6 (Ala114Val) appear to reduce this enzyme's activity. Pr
## Abstract We investigated the significances of the expressions of dihydrodiol dehydrogenase (DDH) and glutathione‐S‐transferase (GST) in patients with esophageal squamous cell carcinoma (ESCC). By using immunohistochemistry, we measured expressions of DDH, GST, COX‐2, nm23‐H1, HER‐2/neu and mdr‐1
## Background: This meta-analysis was conducted to compare the effects of single agent versus combination chemotherapy on response rate, toxicity, and survival of patients with advanced nonsmall cell lung carcinoma (nsclc). ## Methods: The authors reviewed randomized clinical trials published in